First quarter 2019


Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER

First quarter 2019 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

Our strong first quarter performance is a continuation of the momentum that began in the second half of 2018

Olivier Brandicourt

Chief Executive Officer


Download the audio mp3 file


Clinical trials appendix

Press release

Q1 2019 income statements

Q1 2019 net sales by GBU, franchise, geographic region and product

Download infographic

Pre-quarterly results communication